Sidley-Advised Diagnostics Co. Raises $225M In Funding
Venture capital firm DFJ Growth has led a $225 million fundraising campaign for Sidley Austin LLP-advised Delfi Diagnostics, a company that has developed liquid biopsy tests for detecting and monitoring cancer...To view the full article, register now.
Already a subscriber? Click here to view full article